548 related articles for article (PubMed ID: 8820192)
41. Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy.
Kulhanjian JA; Soroush V; Au DS; Bronzan RN; Yasukawa LL; Weylman LE; Arvin AM; Prober CG
N Engl J Med; 1992 Apr; 326(14):916-20. PubMed ID: 1311799
[TBL] [Abstract][Full Text] [Related]
42. Prevalence of specific herpes simplex virus-2 antibodies and associated factors in women of a rural town of Colombia.
Sierra CA; Bedoya AM; Paris S; Baena A; Gaviria AM; Rojas CA; Arbelaez MP; Sanchez GI
Trans R Soc Trop Med Hyg; 2011 Apr; 105(4):232-8. PubMed ID: 21353272
[TBL] [Abstract][Full Text] [Related]
43. A seroprevalence study of herpes virus type 2 infection in Israeli women: implications for routine screening.
Isacsohn M; Bar On E; Yaeger Y; Smetana Z; Weiner D; Slater PE
Isr J Med Sci; 1994; 30(5-6):379-83. PubMed ID: 8034487
[TBL] [Abstract][Full Text] [Related]
44. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
Langenberg AG; Corey L; Ashley RL; Leong WP; Straus SE
N Engl J Med; 1999 Nov; 341(19):1432-8. PubMed ID: 10547406
[TBL] [Abstract][Full Text] [Related]
45. Analysis of the epidemiology and pathogenesis of herpes simplex virus (HSV) infections in pregnant women and infants using the HSV-2 glycoprotein G antibody assay.
Arvin AM; Prober CG
Infect Agents Dis; 1993 Dec; 2(6):375-82. PubMed ID: 8012738
[No Abstract] [Full Text] [Related]
46. Seroepidemiology of Herpes Simplex virus type 1 and 2 in Western and Southern Switzerland in adults aged 25-74 in 1992-93: a population-based study.
Bünzli D; Wietlisbach V; Barazzoni F; Sahli R; Meylan PR
BMC Infect Dis; 2004 Mar; 4():10. PubMed ID: 15113449
[TBL] [Abstract][Full Text] [Related]
47. [Herpes simplex infection as a sexually transmitted disease].
Stary A; Söltz-Szöts J
Wien Klin Wochenschr; 1983 Dec; 95(23):823-7. PubMed ID: 6689458
[TBL] [Abstract][Full Text] [Related]
48. Herpes simplex virus 2 infection in women attending an antenatal clinic in Fuzhou, China.
Chen XS; Yin YP; Chen LP; Yu YH; Wei WH; Thuy NT; Smith JS
Sex Transm Infect; 2007 Aug; 83(5):369-70. PubMed ID: 17475682
[TBL] [Abstract][Full Text] [Related]
49. Seroepidemiology of herpes simplex virus type 1 and 2 in pregnant women in Switzerland: an obstetric clinic based study.
Kucera P; Gerber S; Marques-Vidal P; Meylan PR
Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):13-7. PubMed ID: 21982938
[TBL] [Abstract][Full Text] [Related]
50. Seroprevalence of herpes simplex virus types 1 and 2--United States, 1999-2010.
Bradley H; Markowitz LE; Gibson T; McQuillan GM
J Infect Dis; 2014 Feb; 209(3):325-33. PubMed ID: 24136792
[TBL] [Abstract][Full Text] [Related]
51. Herpes simplex virus type 2 seroepidemiology in Spain: prevalence and seroconversion rate among sexually transmitted disease clinic attendees.
Varela JA; García-Corbeira P; Agüanell MV; Boceta R; Ballesteros J; Aguilar L; Vázquez-Valdés F; Dal-ré R
Sex Transm Dis; 2001 Jan; 28(1):47-50. PubMed ID: 11196047
[TBL] [Abstract][Full Text] [Related]
52. A prospective study of the relationship between genital herpes and carcinoma of the uterine cervix. I. Seroepidemiology of herpes simplex virus type 1 and type 2 in women with a previous history of clinically diagnosed genital herpes.
Vestergaard BF
Dev Biol Stand; 1982; 52():95-8. PubMed ID: 6299863
[TBL] [Abstract][Full Text] [Related]
53. [Genital herpes--epidemiological and clinical issue still of importance].
Serwin AB; Musiałkowska E; Chodynicka B
Przegl Epidemiol; 2010; 64(3):381-5. PubMed ID: 20976950
[TBL] [Abstract][Full Text] [Related]
54. Recurrences after oral and genital herpes simplex virus infection. Influence of site of infection and viral type.
Lafferty WE; Coombs RW; Benedetti J; Critchlow C; Corey L
N Engl J Med; 1987 Jun; 316(23):1444-9. PubMed ID: 3033506
[TBL] [Abstract][Full Text] [Related]
55. Underdiagnosis of genital herpes by current clinical and viral-isolation procedures.
Koutsky LA; Stevens CE; Holmes KK; Ashley RL; Kiviat NB; Critchlow CW; Corey L
N Engl J Med; 1992 Jun; 326(23):1533-9. PubMed ID: 1315930
[TBL] [Abstract][Full Text] [Related]
56. HSV-1 and HSV-2 seroprevalence in the united states among asymptomatic women unaware of any herpes simplex virus infection (Herpevac Trial for Women).
Schulte JM; Bellamy AR; Hook EW; Bernstein DI; Levin MJ; Leone PA; Sokol-Anderson ML; Ewell MG; Wolff PA; Heineman TC; Belshe RB
South Med J; 2014 Feb; 107(2):79-84. PubMed ID: 24926671
[TBL] [Abstract][Full Text] [Related]
57. Selected epidemiological features of herpes genitalis in Israel based on laboratory data.
Smetana Z; Dulitzky M; Movshovitz M; Isacsohn M; Seidman D; Leventon-Kriss S
Isr J Med Sci; 1994; 30(5-6):375-9. PubMed ID: 8034486
[TBL] [Abstract][Full Text] [Related]
58. Prevalence and association between herpes simplex virus types 1 and 2-specific antibodies in attendees at a sexually transmitted disease clinic.
Roest RW; van der Meijden WI; van Dijk G; Groen J; Mulder PG; Verjans GM; Osterhaus AD
Int J Epidemiol; 2001 Jun; 30(3):580-8. PubMed ID: 11416087
[TBL] [Abstract][Full Text] [Related]
59. Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.
Görander S; Mbwana J; Lyamuya E; Lagergård T; Liljeqvist JA
Clin Vaccine Immunol; 2006 Jun; 13(6):633-9. PubMed ID: 16760320
[TBL] [Abstract][Full Text] [Related]
60. Decreasing prevalence of herpes simplex virus-2 antibodies in selected groups of women in Sweden.
Berntsson M; Tunbäck P; Ellström A; Krantz I; Löwhagen GB
Acta Derm Venereol; 2009 Nov; 89(6):623-6. PubMed ID: 19997695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
